
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.670 | 10.110 | 2.440 |
Shares | 92.290 | 92.290 | 0.000 |
Other | 0.040 | 0.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.466 | 18.087 |
Price to Book | 4.054 | 2.993 |
Price to Sales | 3.102 | 2.271 |
Price to Cash Flow | 16.539 | 12.121 |
Dividend Yield | 1.947 | 2.404 |
5 Years Earnings Growth | 8.379 | 10.131 |
Name | Net % | Category Average |
---|---|---|
Industrials | 26.220 | 21.566 |
Financial Services | 24.580 | 20.286 |
Technology | 16.990 | 14.445 |
Healthcare | 9.060 | 10.390 |
Basic Materials | 7.300 | 6.305 |
Communication Services | 6.260 | 5.872 |
Consumer Cyclical | 5.680 | 10.023 |
Consumer Defensive | 3.920 | 7.459 |
Number of long holdings: 57
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Relx | GB00B2B0DG97 | 3.30 | 3,666.00 | +0.55% | |
Schneider Electric | FR0000121972 | 3.09 | 220.30 | +2.54% | |
Deutsche Boerse | DE0005810055 | 3.04 | 259.0000 | +1.29% | |
Wolters Kluwer | NL0000395903 | 2.69 | 124.20 | +0.49% | |
EssilorLuxottica | FR0000121667 | 2.69 | 252.20 | +1.16% | |
SAP | DE0007164600 | 2.64 | 254.750 | +2.37% | |
Diploma | GB0001826634 | 2.47 | 5,420.00 | +0.18% | |
Safran | FR0000073272 | 2.36 | 291.20 | +0.38% | |
Air Liquide | FR0000120073 | 2.27 | 173.58 | +1.06% | |
AstraZeneca | GB0009895292 | 2.21 | 10,950.0 | -0.94% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Norrep Global Income Growth Class A | 243.1M | 2.19 | 12.26 | 7.25 | ||
Norrep Global Income Growth Class F | 243.1M | 2.74 | 13.46 | 8.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review